We joined the European Commission for the control of Foot and Mouth Disease (@eufmd) in its Open Session 2022 (OS22), where we explored the challenges and opportunities offered by digital transformation and innovation applied to the prevention and control of FMD and similar transboundary diseases.

At @Biogénesis Bagó we talked with colleagues, academics and authorities about the importance of safe, effective and high-quality biotechnological solutions as tools for a rapid and effective emergency response.

At the same time, we presented our work, focused on the immunity achieved by our vaccines, their protection capacity against circulating strains in East and Southeast Asia, the Middle East and North Africa and an evaluation of the available tools for the detection of antibodies against structural proteins of the FMD virus.

We continue contributing with world-class solutions and services to the control and eradication of FMD worldwide.

Scan to more info: